Compare Exelixis Inc. Common Stock (EXEL) vs Payoneer Global Inc (PAYO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Exelixis Inc. Common Stock vs Payoneer Global Inc — how do they compare? Exelixis Inc. Common Stock trades at $59.86 (market cap $14.62B), while Payoneer Global Inc trades at $7.14 (market cap $2.43B). The key difference: Exelixis Inc. Common Stock is far larger — about 6× Payoneer Global Inc's market cap, and Exelixis Inc. Common Stock is more actively traded (2,684,957 versus 1,342,701). Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 1 Days and Payoneer Global Inc for 61 Days on average.
| EXEL | PAYO | |
|---|---|---|
Market Cap | $14.62B | $2.43B |
Volume | 2,684,957 | 1,342,701 |
Sector | Health | Technology |
52-Week High | $59.86 | $7.18 |
52-Week Low | $34.54 | $4.27 |
Typical Hold Time | 1 Days | 61 Days |
Enterprise Value | $13.95B | $2.17B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Payoneer Global (PAYO) trades at $7.16 with a bullish technical signal supported by moving averages, though oscillators show neutral momentum. The company reported Q2 2026 earnings of $0.02 per share, missing estimates, but revenue grew 10% excluding interest. Recent news highlights the renewal of Payoneer's partnership with Etsy through 2029 and an agreement to be acquired by Nuvei, announced on June 15, 2026.
The outlook is mixed: analyst consensus is 60% buy with no sell ratings, but earnings misses and a high P/E of 51.18 pose valuation concerns. Key risks include integration challenges from the Nuvei acquisition and competitive pressures in fintech. Upside potential hinges on execution of B2B growth and expansion in India.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Exelixis Inc. Common Stock
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →About Payoneer Global Inc
Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →
